The glucosamine supplement market is projected to grow from USD 641.0 million in 2025 to USD 1,024.4 million by 2035, at a CAGR of 4.8%. Capsules will dominate with a 42.7% market share, while n-acetyl glucosamine will lead the product type segment with a 47.3% share.